William Garrett Nichols, Chief Medical Officer at Candel Therapeutics, Inc. (CADL), sold 21,750 shares at $6.47 ($141K) on 2024-07-17, disclosed to the SEC on 2024-07-19.
Open-market sale of $141k CADL by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.47 | 10,875 | $70K | 50.0% |
| 2 | $6.47 | 10,875 | $70K | 50.0% |
| Total | $6.47 avg | 21,750 | $141K | 100% |
| Filing → |
| CADL | SELL | 2025-03-20 | $794K | — | Filing → |
| CADL | SELL | 2025-01-17 | $151K | — | Filing → |
| CADL | SELL | 2025-01-10 | $178K | — | Filing → |